What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Internal medicine
The scientist’s investigation covers issues in Immunology, Cytotoxic T cell, CD8, Virology and Cancer research.
His Immunology study frequently links to adjacent areas such as Downregulation and upregulation.
His research in Cytotoxic T cell focuses on subjects like In vivo, which are connected to Fibronectin, Immunotherapy and Antibody.
Eui-Cheol Shin has included themes like Blockade, PD-L1, Interleukin-7 receptor, Cell biology and Lung cancer in his CD8 study.
While the research belongs to areas of Virology, Eui-Cheol Shin spends his time largely on the problem of Interleukin 21, intersecting his research to questions surrounding Interferon gamma and Natural killer T cell.
Eui-Cheol Shin has researched Cancer research in several fields, including Apoptosis and Cytokine.
His most cited work include:
- MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells (260 citations)
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. (199 citations)
- Peripheral CD4+CD8+ T cells are differentiated effector memory cells with antiviral functions (192 citations)
What are the main themes of his work throughout his whole career to date?
Eui-Cheol Shin focuses on Immunology, Virology, CD8, Cytotoxic T cell and Immune system.
He regularly links together related areas like Epitope in his Virology studies.
His studies in CD8 integrate themes in fields like Ex vivo, Cancer research and Immunophenotyping, Flow cytometry.
The Immune system study which covers Cytokine that intersects with Tumor necrosis factor alpha.
His work deals with themes such as Internal medicine and Antibody, which intersect with T cell.
His studies in Hepatitis C virus integrate themes in fields like Molecular biology and Hepatocellular carcinoma.
He most often published in these fields:
- Immunology (45.70%)
- Virology (25.77%)
- CD8 (23.71%)
What were the highlights of his more recent work (between 2019-2021)?
- CD8 (23.71%)
- Immunology (45.70%)
- Immune system (21.65%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include CD8, Immunology, Immune system, Cytotoxic T cell and Cancer research.
Eui-Cheol Shin interconnects Phenotype, T cell, Peripheral blood mononuclear cell and Lung cancer in the investigation of issues within CD8.
His research combines Pneumonia and Immunology.
His research integrates issues of Internal medicine, Viral shedding, Antibody and Oncology in his study of Immune system.
His Cytotoxic T cell study combines topics in areas such as Molecular biology, Ex vivo, Antigen and T-cell receptor.
His Cancer research research is multidisciplinary, incorporating elements of Cancer, Cytokine, Tumor-infiltrating lymphocytes, Cancer immunotherapy and Flow cytometry.
Between 2019 and 2021, his most popular works were:
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. (199 citations)
- The type I interferon response in COVID-19: implications for treatment. (75 citations)
- Exosome-based delivery of super-repressor IκBα relieves sepsis-associated organ damage and mortality. (29 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Cancer
CD8, Immunology, Cytotoxic T cell, Immune system and Internal medicine are his primary areas of study.
The CD8 study combines topics in areas such as T cell and Cytokine secretion.
His Immunology research is multidisciplinary, relying on both Severity of illness and Downregulation and upregulation.
Eui-Cheol Shin combines subjects such as Cancer research, Tumor-infiltrating lymphocytes, Influenza A virus and Antigen with his study of Cytotoxic T cell.
His Immune system study incorporates themes from RNA virus, Antibody, Hepatitis C virus and Virology.
Adverse effect, Regorafenib, Hepatocellular carcinoma, Neutrophil to lymphocyte ratio and Survival rate is closely connected to Oncology in his research, which is encompassed under the umbrella topic of Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
